Pro-B acute lymphoblastic leukemia in a patient with severe congenital neutropenia: An unusual form of malignant evolution

Leukemia and Lymphoma

Volumn 54, Issue 10, 2013, Pages 2325-2327

  Juncà, Jordi ^a   Millá, Fuensanta ^a   Xicoy, Blanca ^a   García Caro, Montse ^a   Rodríguez Hernández, Inés ^a   Aróstegui, Juan I ^b  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CSF3R PROTEIN; G6PC3 PROTEIN; GFI1 PROTEIN; GRANULOCYTE COLONY STIMULATING FACTOR; HAX1 PROTEIN; MEMBRANE PROTEIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; UNCLASSIFIED DRUG; WAS PROTEIN;

ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE OTITIS MEDIA; ADULT; AUTOSOMAL DOMINANT INHERITANCE; AUTOSOMAL RECESSIVE INHERITANCE; B CELL LEUKEMIA; BONE MARROW; CASE REPORT; DISEASE COURSE; DRUG DOSE TITRATION; GENE MUTATION; GENETIC RISK; HUMAN; INDUCTION CHEMOTHERAPY; LETTER; MALE; MOLECULAR EVOLUTION; MORBIDITY; MORTALITY; MYELODYSPLASTIC SYNDROME; NEUTROPHIL COUNT; PRIORITY JOURNAL; PROMYELOCYTE; RISK FACTOR; SEVERE CONGENITAL NEUTROPENIA; SOMATIC MUTATION; THRUSH;

HUMANS; MALE; NEUTROPENIA; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; YOUNG ADULT;

EID: 84884483563     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2013.773999     Document Type: Letter

References (13)

1. Donadieu J, Leblanc T, Bader Meunier B, et al. Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia Study. Haematologica 2005; 90: 45-53.
2. Rosenberg PS, Zeidler C, Bolyard AA, et al. Stable long-risk of leukaemia in patients with severe congenital neutropenia maintained on G-CSF therapy. Br J Haematol 2010; 150: 196-199.
3. Beekman R, Touw IP. G-CSF and its receptor in myeloid malignancy. Blood 2010; 115: 5131-5136.
4. Cassinat B, Bellanné-Chantelot C, Notz-Carrère A, et al. Screening for G-CSF receptor mutations in patients with secondary myeloid or lymphoid transformation of severe congenital neutropenia. A report from the French neutropenia register. Leukemia 2004; 18: 1553-1555.
5. Germeshausen M, Bellmaier M, Welte K. Incidence of CSF3R mutations in severe congenital neutropenia and relevance for leukemogenesis: Results of a long-term survey. Blood 2007; 109: 93-99.
6. Germeshausen M, Ballmaier M, Schulze H, et al. Granulocyte colony-stimulating factor receptor mutations in a patient with acute lymphoblastic leukemia secondary to severe congenital neutropenia. Blood 2001; 97: 829-830.
7. Yetgin S, Germeshausen M, Touw I, et al. Acute lymphoblastic leukemia in a patient with congenital neutropenia without G-CSF and ELA2 mutations. Leukemia 2005; 19: 1710-1711.
8. Valera ET, Brassesco MS, Germeshausen M, et al. Acute lymphoblastic leukemia following severe congenital neutropenia or de novo ALL? Leuk Res 2009; 33: E139-e142.
9. Bene MC, Castoldi G, Knapp W, et al. Proposals for the immunological classification of acute leukemias. Leukemia 1995; 9: 1783-1786.
10. Zeidler C, Germeshausen M, Klein C, et al. Clinical implications of ELA2-, HAX1- and G-CSF-receptor (CSF3R) mutations in severe congenital neutropenia. Br J Haematol 2008; 144: 459-467.
11. Germeshausen M, Welte K, Ballmaier M.in vivo expansion of cells expressing acquired CSF3R mutations in patients with severe congenital neutropenia. Blood 2009; 113: 668-670.
12. Yetgin S, Olcay L, KoçA, et al. Transformation of severe congenital neutropenia to early acute lymphoblastic leukemia in a patient with HAX1 mutation and without G-CSF administration or receptor mutation. Leukemia 2008; 22: 1797.
13. Carlsson G, Fasth A, Berglöf E, et al. Incidence of severe congenital neutropenia in Sweden and risk of evolution to myelodysplastic syndrome/leukemia. Br J Haematol 2012; 158: 363-369.